EPISODE · Feb 10, 2020 · 11 MIN
Crispr'd Cells Show Promise in First US Human Safety Trial
from Science, Spoken · host SpokenLayer
It’s been over three years since US regulators greenlit the nation’s first in-human test of Crispr’s disease-fighting potential, more than three years of waiting to find out if the much-hyped gene-editing technique could be safely used to beat back tough-to-treat cancers. Today, researchers from the University of Pennsylvania and Stanford finally revealed the first published report describing the trial. Learn about your ad choices: dovetail.prx.org/ad-choices
What this episode covers
It’s been over three years since US regulators greenlit the nation’s first in-human test of Crispr’s disease-fighting potential, more than three years of waiting to find out if the much-hyped gene-editing technique could be safely used to beat back tough-to-treat cancers. Today, researchers from the University of Pennsylvania and Stanford finally revealed the first published report describing the trial.
NOW PLAYING
Crispr'd Cells Show Promise in First US Human Safety Trial
No transcript for this episode yet
Similar Episodes
No similar episodes found.